Loading...
Docoh

Attar Eyal C.

Attar Eyal C. is SVP, Chief Medical Officer of Aprea Therapeutics Inc.

Person profile

Roles
Aprea Therapeutics SVP, Chief Medical Officer
Address
Boston, Massachusetts
Employees
SEC CIK

Calendar

28 Jun 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
3 Jun 22 APRE Aprea Therapeutics Common Stock Payment of exercise Dispose F No No 0.805 32,667 26.3K 57,233
10 Mar 22 APRE Aprea Therapeutics Common Stock Grant Acquire A No No 0 42,900 0 89,900
10 Mar 22 APRE Aprea Therapeutics Stock Option Common Stock Grant Acquire A No No 1.82 185,900 338.34K 185,900
28 Feb 22 APRE Aprea Therapeutics Common Stock Sell Dispose S No Yes 1.73 36,000 62.28K 47,000
16 Sep 21 APRE Aprea Therapeutics Common Stock Sell Dispose S No Yes 4.68 15,968 74.73K 83,000
25 Aug 21 APRE Aprea Therapeutics Common Stock Payment of exercise Dispose F No No 3.98 9,032 35.95K 98,968
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings